Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

296.52
Delayed Data
As of Jul 22
 -1.59 / -0.53%
Today’s Change
287.66
Today|||52-Week Range
442.00
-20.61%
Year-to-Date

Today’s Trading

Previous close298.11
Today’s open298.20
Day’s range294.70 - 300.32
Volume608,965
Average volume (3 months)841,456
Market cap$32.2B
Data as of 4:00pm ET, 07/22/2019

Growth & Valuation

Earnings growth (last year)+100.98%
Earnings growth (this year)-5.36%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+14.28%
P/E ratio14.0
Price/Sales6.39
Price/Book3.72

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+1.52+1.26%
VRTXVertex Pharmaceutica...-0.05-0.03%
INCYIncyte Corp+1.17+1.45%
SGENSeattle Genetics Inc+1.00+1.33%
Data as of 4:00pm ET, 07/22/2019

Financials

Next reporting dateAugust 6, 2019
EPS forecast (this quarter)$5.32
Annual revenue (last year)$6.7B
Annual profit (last year)$2.4B
Net profit margin36.42%

Profile

Sector
Health Technology
Industry
Biotechnology
Co-President, Chief Executive Officer &
Director
Leonard S. Schleifer
Co-President, Director &
Chief Scientific Officer
George Damis Yancopoulos
Corporate headquarters
Tarrytown, New York

Forecasts